drugset / Trial / NCT04983498

Enhanced Recovery Pathway for Endoscopy

NCT04983498

Phase 4 Withdrawn Northwestern University
Non-randomizedFactorialOpen-labelPrevention

Summary

The purpose of this study is to compare an Enhanced Recovery Pathway to the current pre-operative/recovery practices of the endoscopy department on patient post-procedure outcomes.

Timeline

Start
2021-09-01
Primary completion
2021-12-01
Completion
2022-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ondansetron Other / unclassified 4 mg Intravenous
Background Ringer's Lactate Other / unclassified 5 ml Intravenous

Indications

No indication recorded.